Loan & DebtJul 7, 2026, 09:02 AM
Oncology Institute Refinances $86M Debt with OrbiMed
AI Summary
The Oncology Institute, Inc. announced it has repaid its $86 million senior secured convertible note with Deerfield Partners through a debt refinancing. This transaction includes new credit facilities from OrbiMed, featuring a new $75 million term loan maturing in 2031. The company also utilized approximately $11 million in cash from its balance sheet to complete the repayment, aiming to increase liquidity, improve operating flexibility, and extend debt maturities without diluting existing shareholders.
Key Highlights
- Repaid $86 million senior secured convertible note with Deerfield Partners.
- Secured new $75 million term loan from OrbiMed.
- New term loan matures in 2031, extending debt maturities.
- Used approximately $11 million of cash from the balance sheet.
- Transaction increases liquidity and improves operating flexibility.
- Completed the refinancing without raising additional equity or diluting shareholders.
Price Impact
More from TOI